Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardiovascular Effects of Agomelatine vs Escitalopram in MDD
NCT01483053Phase 4Unknown
- Sponsor
- Baker Heart and Diabetes Institute
- Start
- Jan 2014
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of agomelatine in major depressive disorder (MDD), sponsored by Baker Heart and Diabetes Institute. Status: unknown.
02
Drugs
agomelatine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01483053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01483053.